MARKET

GKOS

GKOS

Glaukos Corp
NYSE
141.41
-3.02
-2.09%
Opening 10:14 06/29 EDT
OPEN
142.36
PREV CLOSE
144.42
HIGH
143.70
LOW
139.86
VOLUME
89.66K
TURNOVER
--
52 WEEK HIGH
148.11
52 WEEK LOW
73.16
MARKET CAP
8.31B
P/E (TTM)
-42.9620
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GKOS last week (0622-0626)?
Weekly Report · 10h ago
Can Glaukos (GKOS) Turn Its iLution Eyelid Platform Into a Second Growth Engine Beyond Glaucoma?
Simply Wall St · 2d ago
Glaukos completes patient enrollment in Phase 2 study of GLK-321
TipRanks · 4d ago
Glaukos (GKOS) Gets a Buy from BTIG
TipRanks · 5d ago
Jefferies Remains a Buy on Glaukos (GKOS)
TipRanks · 6d ago
Weekly Report: what happened at GKOS last week (0615-0619)?
Weekly Report · 06/22 10:06
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga · 06/17 13:05
Analysts Conflicted on These Healthcare Names: Simulations Plus (SLP), Incyte (INCY) and Glaukos (GKOS)
TipRanks · 06/17 10:40
More
About GKOS
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce intraocular pressure (IOP) by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce IOP by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders such as keratoconus, among others.

Webull offers Glaukos Corp stock information, including NYSE: GKOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GKOS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GKOS stock methods without spending real money on the virtual paper trading platform.